HOPKINTON, Mass., April 21, 2011 - Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced that Kevin Hrusovsky, Caliper's President and CEO, will present at the 36th Annual Deutsche Bank Health Care Conference in Boston on May 2, 2011 at 10:40 a.m. ET.
A live webcast of the presentation can be accessed at www.corporate-ir.net/ireye/confLobby.zhtml?ticker=CALP&item_id=3909124 or by visiting Caliper's website at www.caliperLS.com. To access the webcast, select "Investors" and find the event under "Investor Events". An archived edition of the presentation will be available for 90 days.
About Caliper Life Sciences
Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results, enabling the translation of those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.
SOURCE Caliper Life Sciences, Inc.
CONTACT: Peter McAree, SVP and CFO of Caliper Life Sciences, +1-774-278-2215
Web Site: www.caliperls.com